![Charles Baum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Baum
Direktör/Styrelseledamot på
PMV PHARMACEUTICALS, INC.
Förmögenhet: 14 986 $ per 2026-05-31
Profil
Charles M.
Baum is Chief Executive Officer & Director at Terremoto Biosciences, Inc. since 2024.
Chairman at Oncomyx Therapeutics, Inc. since 2020.
Independent Director at PMV Pharmaceuticals, Inc. since 2021.
Independent Director at Acrivon Therapeutics, Inc. since 2023.
Director at Crossbow Therapeutics, Inc. Formerly President, Chief Executive Officer & Director at Mirati Therapeutics, Inc. from 2023 to 2024.
Independent Director at Immunomedics, Inc. from 2019 to 2020.
Independent Director at Array BioPharma, Inc. from 2014 to 2019.
Director at Odyssey Therapeutics, Inc. Independent Director at BCTG Acquisition Corp.
from 2020 to 2021.
Independent Director at Poseida Therapeutics, Inc. from 2022 to 2025.
Senior VP & Head-Clinical Research at Pfizer Inc. from 2010 to 2012.
Earned a doctorate from Washington University School of Medicine in 1987.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-17 | 9 366 ( 0,02 % ) | 14 986 $ | 2026-05-31 | |
| 2026-06-04 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Charles Baum
| Företag | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2021-04-01 |
| ACRIVON THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-06-22 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Ordförande | 2020-11-06 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Verkställande Direktör | 2024-07-25 |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Charles Baum
| Företag | Position | Slut |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-01-08 |
| MIRATI THERAPEUTICS | Verkställande Direktör | 2024-01-23 |
| TANGO THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-01-01 |
| IMMUNOMEDICS, INC. | Direktör/Styrelseledamot | 2020-10-23 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Charles Baums utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
82
Första gradens relationer
13
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
